xAnts

Health Check: Joy as Mesoblast wins its first FDA approval for a stem-cell therapy after decades of trying

After years of trying, Mesoblast has won US FDA approval for its stem-cell therapies to treat the fatal graft-versus-host disease. History is made as the FDA approves Mesoblast's Ryoncil for paediatric graft-versus-host disease ...Read more